Cryoport has formed a strategic partnership with fertility technology company TMRW Life Sciences to provide fertility clinics with temperature-controlled management and transport solutions in the US.
The partnership follows increased demands for secure shipping solutions at cryogenic temperatures. Cryoport will lead the transportation of the specimens between TMRW biorepositories and fertility clinics.
At cryogenic temperatures, the specimens are protected from further ageing or damage.
Louis Villalba, CEO of TMRW, said, “Cryoport’s reputation for excellence in reproductive biologistics, paired with TMRW’s cutting-edge specimen management technology and safety certifications, delivers security and peace of mind for transporting specimens in the fertility space.”
... to continue reading you must be subscribed
